New Enro-Tabs® and Clinda-Tabs® are added to Petmedica's porfolio

Posted on 04/02/2021

Enro-Tabs® 150 FT and Enro-Tabs® 50 FT in palatable tablets for the use in cats and dogs is based on enrofloxacin a broad spectrum quinolone with efect against Gram +, Gram -, mycoplasmas and pseudomonas. It is indicated for the treatment of infections in the digestive, urogenital and respiratory tracts, among others.

Clinda-Tabs® 300 FT and Clinda-Tabs® 150 FT, formulated based on clindamycin in palatable tablet presentation. Presents action against aerobic and anaerobic Gram + bacteria; Gram - anaerobes, mycoplasmas and protozoa. Indicated for symptoms of eye, skin, oral, respiratory and bone infections in dogs and cats, as well as in the treatment of toxoplasmosis.


For more information about our product portfolio, we invite you to visit our website:

Search News

Agrovet Market Channel